Fabior

Product manufactured by Mayne Pharma

Application Nr Approved Date Route Status External Links
NDA202428 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fabior ® (Tazarotene) Foam, 0.1% Is Indicated For The Topical Treatment Of Acne Vulgaris In Patients 12 Years Of Age Or Older. Fabior Foam Is A Retinoid Indicated For The Topical Treatment Of Acne Vulgaris In Patients 12 Years Of Age Or Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tazarotene TAZAROTENE ZINC1542199

Comments